Scilex Holding Co's Form 4 filing
Semnur Pharmaceuticals, Inc. (SMNR) · filed Sep 25, 2025
- Accession no.
- 0001193125-25-218151
- Filed
- Sep 25, 2025, 7:49 PM ET
- Trade date
- Sep 23, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $200.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Scilex Holding CoCIK 0001820190 | 10% Owner |
| Scilex, Inc.CIK 0002084647 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2025 | Common Stock | SSaleDisposed | −11,945,151 | $16.00 | −$191,122,416 | 181,804,849 | Indirect | |
| Sep 23, 2025 | Common Stock | SSaleDisposed | −554,849 | $16.00 | −$8,877,584 | 500,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.